InsiderDB
Committee overlap: HELP

Sen. Tommy Tuberville sold Eli Lilly and Company (LLY)

Sen. Tommy Tuberville (R-AL) · $15K–$50K · traded Apr 15, 2025

Why this is a committee overlap

Tuberville is a member of the Senate Committee on Health, Education, Labor, and Pensions, which oversees the Healthcare sector. Eli Lilly and Company is classified in the Drug Manufacturers - General industry.

An overlap is a fact about the trade, not evidence of wrongdoing. Committee assignments are current ones.

Transaction
Sold (full)
Amount
$15K–$50K
Owner
Joint
Traded
Apr 15, 2025
Disclosed
May 15, 2025
Days to disclose
30
Asset type
Stock
As filed
Eli Lilly and Company
Industry
Drug Manufacturers - General · Healthcare

Other trades in this filing

Recent Congress trades in LLY

Company context for LLY

Recent records for the company. These may have been published before or after this trade; compare the dates before drawing a connection.

  1. LLYContract award·USAspending

    LLY: Department of Veterans Affairs contract award

    AMYVID_BETA AMYLOID IMAGING

    First observed: Nov 8, 2026, 7:28 PM ESTEvent / period: Aug 17, 2026Original source ↗

    1 congressional household disclosed purchases in the past 90 days. See the trades

  2. LLYRegulatory notice·Federal Register

    Foreign-Trade Zone 72; Application for Subzone Expansion; Eli Lilly and Company; Brownsburg, Lebanon, and Whitestown, Indiana

    A Notice notice explicitly mentions the company. Read the cited text for its role.

    Public: Nov 2, 2026Original source ↗

    1 congressional household disclosed purchases in the past 90 days. See the trades

  3. LLYFinancial report·SEC EDGAR

    LLY: 10-Q financial filing

    Filed 10-Q for an event or period dated 2026-09-30. Read the company report for its disclosures.

    Public: Oct 29, 2026, 11:35 AM EDTEvent / period: Sep 30, 2026Original source ↗

    1 congressional household disclosed purchases in the past 90 days. See the trades

From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.